{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:32:54Z","timestamp":1778128374042,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"10271","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/s0140-6736(20)32341-2","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T19:45:52Z","timestamp":1611258352000},"page":"305-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":287,"title":["Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial"],"prefix":"10.1016","volume":"397","author":[{"given":"Frances","family":"Humby","sequence":"first","affiliation":[]},{"given":"Patrick","family":"Durez","sequence":"additional","affiliation":[]},{"given":"Maya H","family":"Buch","sequence":"additional","affiliation":[]},{"given":"Myles J","family":"Lewis","sequence":"additional","affiliation":[]},{"given":"Hasan","family":"Rizvi","sequence":"additional","affiliation":[]},{"given":"Felice","family":"Rivellese","sequence":"additional","affiliation":[]},{"given":"Alessandra","family":"Nerviani","sequence":"additional","affiliation":[]},{"given":"Giovanni","family":"Giorli","sequence":"additional","affiliation":[]},{"given":"Arti","family":"Mahto","sequence":"additional","affiliation":[]},{"given":"Carlomaurizio","family":"Montecucco","sequence":"additional","affiliation":[]},{"given":"Bernard","family":"Lauwerys","sequence":"additional","affiliation":[]},{"given":"Nora","family":"Ng","sequence":"additional","affiliation":[]},{"given":"Pauline","family":"Ho","sequence":"additional","affiliation":[]},{"given":"Michele","family":"Bombardieri","sequence":"additional","affiliation":[]},{"given":"Vasco C","family":"Rom\u00e3o","sequence":"additional","affiliation":[]},{"given":"Patrick","family":"Verschueren","sequence":"additional","affiliation":[]},{"given":"Stephen","family":"Kelly","sequence":"additional","affiliation":[]},{"given":"Pier Paolo","family":"Sainaghi","sequence":"additional","affiliation":[]},{"given":"Nagui","family":"Gendi","sequence":"additional","affiliation":[]},{"given":"Bhaskar","family":"Dasgupta","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Cauli","sequence":"additional","affiliation":[]},{"given":"Piero","family":"Reynolds","sequence":"additional","affiliation":[]},{"given":"Juan D","family":"Ca\u00f1ete","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Moots","sequence":"additional","affiliation":[]},{"given":"Peter C","family":"Taylor","sequence":"additional","affiliation":[]},{"given":"Christopher J","family":"Edwards","sequence":"additional","affiliation":[]},{"given":"John","family":"Isaacs","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Sasieni","sequence":"additional","affiliation":[]},{"given":"Ernest","family":"Choy","sequence":"additional","affiliation":[]},{"given":"Costantino","family":"Pitzalis","sequence":"additional","affiliation":[]},{"given":"Charlotte","family":"Thompson","sequence":"additional","affiliation":[]},{"given":"Serena","family":"Bugatti","sequence":"additional","affiliation":[]},{"given":"Mattia","family":"Bellan","sequence":"additional","affiliation":[]},{"given":"Mattia","family":"Congia","sequence":"additional","affiliation":[]},{"given":"Christopher","family":"Holroyd","sequence":"additional","affiliation":[]},{"given":"Arthur","family":"Pratt","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Eurico","family":"Cabral da Fonseca","sequence":"additional","affiliation":[]},{"given":"Laura","family":"White","sequence":"additional","affiliation":[]},{"given":"Louise","family":"Warren","sequence":"additional","affiliation":[]},{"given":"Joanna","family":"Peel","sequence":"additional","affiliation":[]},{"given":"Rebecca","family":"Hands","sequence":"additional","affiliation":[]},{"given":"Liliane","family":"Fossati-Jimack","sequence":"additional","affiliation":[]},{"given":"Gaye","family":"Hadfield","sequence":"additional","affiliation":[]},{"given":"Georgina","family":"Thorborn","sequence":"additional","affiliation":[]},{"given":"Julio","family":"Ramirez","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Celis","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(20)32341-2_bib1","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0140-6736(87)91672-2","article-title":"Long-term outcome of treating rheumatoid arthritis: results after 20 years","volume":"329","author":"Scott","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(20)32341-2_bib2","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(20)32341-2_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1371\/journal.pmed.0060001","article-title":"Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium","volume":"6","author":"Humby","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/S0140-6736(20)32341-2_bib4","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","article-title":"Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin","volume":"122","author":"Harre","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/S0140-6736(20)32341-2_bib5","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"NEJM"},{"key":"10.1016\/S0140-6736(20)32341-2_bib6","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1002\/art.22025","article-title":"Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks","volume":"54","author":"Cohen","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(20)32341-2_bib7","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/art.21778","article-title":"The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial","volume":"54","author":"Emery","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(20)32341-2_bib8","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3899\/jrheum.111488","article-title":"Longterm effects of rituximab on B cell counts and autoantibody production in rheumatoid arthritis: use of high-sensitivity flow cytometry for more sensitive assessment of B cell depletion","volume":"40","author":"V\u00e1ncsa","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/S0140-6736(20)32341-2_bib9","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1002\/art.23902","article-title":"Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis","volume":"58","author":"Dass","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(20)32341-2_bib10","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1136\/ard.2007.080960","article-title":"Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response","volume":"67","author":"Thurlings","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(20)32341-2_bib11","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1136\/annrheumdis-2011-201115","article-title":"Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab","volume":"71","author":"Hogan","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(20)32341-2_bib12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/ard.2008.092791","article-title":"Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation","volume":"68","author":"Teng","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(20)32341-2_bib13","doi-asserted-by":"crossref","first-page":"R90","DOI":"10.1186\/ar4555","article-title":"Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics","volume":"16","author":"Dennis","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/S0140-6736(20)32341-2_bib14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/annrheumdis-2018-214539","article-title":"Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients","volume":"78","author":"Humby","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(20)32341-2_bib15","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41584-020-0491-4","article-title":"Transforming clinical trials in rheumatology: towards patient-centric precision medicine","volume":"16","author":"Pitzalis","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/S0140-6736(20)32341-2_bib16","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(20)32341-2_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/annrheumdis-2013-204603","article-title":"Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients","volume":"74","author":"Kelly","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(20)32341-2_bib19","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/art.10556","article-title":"Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: implications for pathogenesis and evaluation of treatment","volume":"46","author":"Kraan","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0140-6736(20)32341-2_bib20","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.41184","article-title":"B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure","volume":"72","author":"Rivellese","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/S0140-6736(20)32341-2_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/rheumatology\/39.1.43","article-title":"Quantification of the cell infiltrate in synovial tissue by digital image analysis","volume":"39","author":"Kraan","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/S0140-6736(20)32341-2_bib22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2559.2006.02508.x","article-title":"Synovitis score: discrimination between chronic low-grade and high-grade synovitis","volume":"49","author":"Krenn","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/S0140-6736(20)32341-2_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/S0140-6736(20)32341-2_bib24","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/S0140-6736(20)32341-2_bib25","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nature13182","article-title":"A promoter-level mammalian expression atlas","volume":"507","author":"Forrest","year":"2014","journal-title":"Nature"},{"key":"10.1016\/S0140-6736(20)32341-2_bib26","doi-asserted-by":"crossref","first-page":"R796","DOI":"10.1186\/ar1740","article-title":"Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score","volume":"7","author":"Aletaha","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/S0140-6736(20)32341-2_bib27","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrrheum.2017.115","article-title":"Synovial tissue research: a state-of-the-art review","volume":"13","author":"Orr","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/S0140-6736(20)32341-2_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2011-201117","article-title":"Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis","volume":"72","author":"Isaacs","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0140-6736(20)32341-2_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/his.12904","article-title":"Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome","volume":"69","author":"Beckers","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/S0140-6736(20)32341-2_bib30","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in Inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/S0140-6736(20)32341-2_bib31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrclinonc.2010.84","article-title":"Molecular circuits of solid tumors: prognostic and predictive tools for bedside use","volume":"7","author":"Fert\u00e9","year":"2010","journal-title":"Nat Rev Clin Oncol"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673620323412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673620323412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:21:46Z","timestamp":1758846106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673620323412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":30,"journal-issue":{"issue":"10271","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0140673620323412"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(20)32341-2","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(20)32341-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(20)32652-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}